NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,008 filers reported holding NOVARTIS A G in Q4 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $596,883 | +84.2% | 5,915 | +65.6% | 0.17% | +29.2% |
| Q4 2022 | $324,052 | -54.0% | 3,572 | -61.5% | 0.13% | -52.6% |
| Q3 2022 | $704,000 | +12.8% | 9,266 | +25.5% | 0.27% | -12.2% |
| Q2 2022 | $624,000 | +74.3% | 7,386 | +88.4% | 0.31% | -4.3% |
| Q2 2021 | $358,000 | +72.1% | 3,920 | +64.4% | 0.33% | +18.5% |
| Q2 2020 | $208,000 | -55.0% | 2,385 | -55.1% | 0.28% | -34.7% |
| Q3 2019 | $462,000 | -13.5% | 5,316 | -14.5% | 0.42% | +48.8% |
| Q4 2018 | $534,000 | -6.0% | 6,219 | -5.7% | 0.28% | +14.1% |
| Q3 2018 | $568,000 | +50.3% | 6,594 | +49.9% | 0.25% | +131.8% |
| Q3 2017 | $378,000 | -3.6% | 4,400 | -6.4% | 0.11% | -21.3% |
| Q2 2017 | $392,000 | +30.7% | 4,700 | +23.7% | 0.14% | -23.2% |
| Q3 2016 | $300,000 | -40.4% | 3,800 | -37.7% | 0.18% | -27.5% |
| Q2 2016 | $503,000 | +73.4% | 6,100 | +52.5% | 0.24% | +25.8% |
| Q1 2016 | $290,000 | – | 4,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |